ArticleFrontiers in oncology2026

Universal CD7-targeted CAR T-cell therapy in T-ALL: a promising bridge to transplant, but not without caveats-a critical reappraisal.

Qinghua Ke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.